News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Pages

Press Releases

Read our latest news.

  • Johnson & Johnson Announces Completion of Acquisition of Actelion

    New Brunswick
    16 June 2017

    Transaction Expands Janssen Portfolio with Leading Differentiated In-Market Medicines and Promising Late-Stage Therapies.

  • Johnson & Johnson Innovation Announces New Collaborations Advancing Ground-Breaking Biomedical Innovation Around the Globe

    New Brunswick
    15 June 2017

    Innovation portfolio grows with collaborations advancing potential treatments for obesity and related complications such as diabetes and non-alcoholic steatohepatitis (NASH), novel therapeutics for rheumatoid arthritis; 3-D printing of custom health solutions New efforts underway to advance global public health through sharing access to Janssen molecular libraries.

  • Janssen and Johnson & Johnson Innovation Launch Next-Gen Baby Box QuickFire Challenge in Collaboration with Sitra, Tekes and VTT

    Helsinki, Finland
    08 June 2017

    Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Johnson & Johnson Innovation, in collaboration with Finnish Innovation Fund Sitra, Tekes – the Finnish Funding Agency for Innovation and VTT Technical Research Centre of Finland, announced today the launch of the Next-Gen Baby Box QuickFire Challenge focused on creating "the Baby Box of the future" to promote child health, detect childhood disease earlier and facilitate healthy parenting. 

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.